Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, May 17, 2012
Technology Networks
 
Register | Sign in
Home Page
  Permissions

Permission to use, copy and distribute documents presented on this World Wide Web site and related graphics is not granted without prior written permission of Technology Networks Ltd

To obtain this permission contact:
Technology Networks Ltd
Unit 6, Woodview
Bull Lane
Acton
Sudbury
CO10 0FD, U.K.

In cases where permission is granted, it is done so under the provision that the above copyright notice and this permission notice appear in all copies. All other rights are reserved.

The information and data included in the TechnologyNetworks.com WWW site, and all its affiliated websites and associated email newsletters, have been compiled from a variety of sources, and are subject to change without notice. Technology Networks Ltd. makes no warranties or representations whatsoever regarding the quality, content, completeness, or adequacy of this information and data.

Technology Networks Ltd. specifically disclaims all warranties with respect to this WWW site, email newsletters or your use thereof, express, implied, or otherwise, including without limitation, all warranties of merchantability and fitness for a particular purpose. Technology Networks Ltd shall not be liable for any special, incidental, or consequential damages, including, without limitation, lost revenues, lost profits, or loss of prospective economic advantage, resulting from the use or misuse of this site, or the information therein.

Scientific News
Pharmacokinetics, Metabolism and Toxicity of Carbon Nanotubes for Biomedical Purposes
This study reviews the updated data of CNTs from the biomedical view with focus on the pharmacokinetics, metabolism and toxicity of CNTs in vivo.
Fall in Deaths Following Withdrawal of Pain Killer
Reduction in deaths after withdrawn of pain-relief drug co-proxamol in UK.
Urinary Excretion of Platinum, Arsenic and Selenium of Cancer Patients Treated with Platinum-Based Drugs
Arsenic exposure increases the risk of non-cancerous and cancerous diseases. This study characterised the short-term urinary excretion amounts of arsenic, selenium and platinum in 24-h urine samples from patients with lung cancer and those with other types of cancer.
Urinary Excretion of Platinum, Arsenic and Selenium of Cancer Patients Treated with Platinum-Based Drugs
Arsenic exposure increases the risk of non-cancerous and cancerous diseases. This study characterised the short-term urinary excretion amounts of arsenic, selenium and platinum in 24-h urine samples from patients with lung cancer and those with other types of cancer.
Inroads to Predict in Vivo Toxicology—An Introduction to the eTOX Project
The main barrier for a new drug to enter into clinical development is the preclinical evaluation of toxicity. This project aims to be a database consisting of preclinical toxicity data for drug compounds or candidates extracted from, previously unpublished, legacy reports.
Real-Time Visualization and Quantitation of Vascular Permeability In Vivo: Implications for Drug Delivery
This paper presents an integrated method to visualize and quantify the real-time dynamics of dextrans in a shell-less chick chorioallantoic (CAM) model.
Preclinical Predictors of Anticancer Drug Efficacy: Critical Assessment with Emphasis on Nanomolar Potency
This article looks at prediction of cancer drug efficacy in its ultimate user, the human patient and reviews current knowledge followed by illustrative examples that, in the absence of definitive data, provide an empirical perspective.
Direct Drug Metabolism Monitoring in a Live Single Hepatic Cell by Video Mass Spectrometry
This study of live single-cell level drug metabolism analysis opens the possibility of speedy, low-cost and site-specific monitoring of drug metabolism and a useful tool for single-cell tailored medicine using biopsied cells.
Evaluation of Drug Administration Errors in a Teaching Hospital
The evaluation and improvement of drug administration process are key elements in patient safety. Researchers directly observed the frequency, type, potential clinical significance and determinants of drug administration errors detected in adult in-patients, with the aim to overcome methodological limitations.
Global Patterns of Genetic Diversity and Signals of Natural Selection for Human ADME Genes
This study is the first to systematically investigate worldwide population differentiation and potential signals of natural selection in a comprehensive list of ADME genes.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Get The App
Go to LabTube.tv
Go to ePosters.net